Victory Square Technologies Inc. (6F6.F)
Chart Events
Performance Outlook
| Previous Close | 0.0756 |
| Open | 0.0719 |
| Bid | 0.0763 x 250000 |
| Ask | 0.0973 x 250000 |
| Day's Range | 0.0717 - 0.0719 |
| 52 Week Range | 0.0599 - 0.1700 |
| Volume | |
| Avg. Volume | 39 |
| Market Cap | 8.387M |
| Beta (5Y Monthly) | 1.41 |
| PE Ratio (TTM) | 0.40 |
| EPS (TTM) | 0.1800 |
| Earnings Date | Nov 30, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Hydreight Technologies Provides Corporate Update
Hydreight Technologies’ CEO and President, Shane Madden, provides an update on the Company’s 2022 performance and 2023 outlookVANCOUVER, British Columbia and LAS VEGAS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS)(FSE: SO6) a fast-growing telehealth platform and medical network enabling flexible home healthcare, is pleased to provide a corporate update from CEO and President, Shane Madden. Dear Hydreight Shareholders: 2022 was a pivota
- GlobeNewswire
Hydreight Technologies Inc. Appoints Dr. Jeremy Roebuck to Board of Advisors
With over two decades of medical experience, Dr. Roebuck is an ENT specialist, a board-certified otolaryngologist, a highly trained otologist and has been recognized for his academic achievements and a recipient of multiple professional awards.Dr. Roebuck is the owner and Medical Director of The Med Spa, a modern innovative facility offering a multitude of anti-aging, rejuvenation, hydration and wellness services.Hydreight started trading under the symbol ‘NURS’ on the TSX Venture Exchange at ma
- GlobeNewswire
Hydreight Technologies Inc. Reports Nine Months Ended September 30, 2022
Hydreight Technologies Inc. started trading under the symbol ‘NURS’ on the TSX Venture Exchange at market open on December 1, 2022.Hydreight’s licenses, medical director offering, and technology allow med-spas as well as healthcare professionals to be able to offer wellness services, testing, medical and medispa treatments all in the comfort of home or at any other location of the customer’s choice.Adjusted revenue (see Use of Non-GAAP Financial Measures) for the three months ended September 30,
